HB4640Introduced in the House of Delegates
Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration
Introduced by Evan Worrell, District 23
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
The purpose of this bill is to add crystalline polymorph psilocybin in the permitted list of distributed and prescribed drugs, if approved by the United States Food and Drug Administration and scheduled by the United States Drug Enforcement Administration.
Where it stands
On 1st reading, House Calendar
February 2, 2026
How did lawmakers vote?
No recorded vote is available for this bill yet.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
Bill history
Filed for introduction
To Health and Human Resources
Introduced in House
To House Health and Human Resources
Markup Discussion
By substitute, do pass
On 1st reading, Special Calendar
Postponed on 1st reading, Special Calendar, until January 30, 2026
Placed on House Calendar
On 1st reading, House Calendar
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.